Amryt Pharma Plc (AMYT):企業の財務・戦略的SWOT分析

◆英語タイトル:Amryt Pharma Plc (AMYT) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH417512FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Amryt Pharma Plc (AMYT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Amryt Pharma Plc (Amryt Pharma) is a biopharmaceutical company which develops and commercializes novel treatments for patients with rare and orphan diseases. It has two marketed products include lomitapide for the treatment of adult HoFH and Metreleptin for the treatment of leptin deficiency. The company is also developing a portfolio of pipeline candidates, AP101 and AP103 targeting multiple orphan diseases such as epidermolysis bullosa. The company offers its products in the US, European Middle East and Africa (EMEA). Amryt Pharma is headquartered in London, the UK.

Amryt Pharma Plc Key Recent Developments

Nov 05,2020: Amryt reports record Q3 2020 results – raising FY 2020 revenue guidance
Aug 07,2020: Amryt to present at Virtual Canaccord Genuity 40th Annual Growth Conference
Aug 06,2020: Amryt announces Q2 2020 results
Aug 06,2020: Amryt announces Q2 2020 results and issues positive revenue guidance for FY 2020
May 11,2020: Amryt Pharma : Q1 2020 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Amryt Pharma Plc – Key Facts
Amryt Pharma Plc – Key Employees
Amryt Pharma Plc – Key Employee Biographies
Amryt Pharma Plc – Major Products and Services
Amryt Pharma Plc – History
Amryt Pharma Plc – Company Statement
Amryt Pharma Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Amryt Pharma Plc – Business Description
Product Category: Lojuxta
Performance
Product Category: Lomitapide
Overview
Product Category: Metreleptin
Overview
Performance
Product Category: Others
Overview
Performance
Geographical Segment: EMEA
Performance
Geographical Segment: Other
Performance
Geographical Segment: The US
Performance
R&D Overview
Amryt Pharma Plc – Corporate Strategy
Amryt Pharma Plc – SWOT Analysis
SWOT Analysis – Overview
Amryt Pharma Plc – Strengths
Amryt Pharma Plc – Weaknesses
Amryt Pharma Plc – Opportunities
Amryt Pharma Plc – Threats
Amryt Pharma Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Oil & Gas Financial Deals and Alliances
Amryt Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amryt Pharma Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amryt Pharma Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 05, 2020: Amryt reports record Q3 2020 results – raising FY 2020 revenue guidance
Aug 07, 2020: Amryt to present at Virtual Canaccord Genuity 40th Annual Growth Conference
Aug 06, 2020: Amryt announces Q2 2020 results
Aug 06, 2020: Amryt announces Q2 2020 results and issues positive revenue guidance for FY 2020
May 11, 2020: Amryt Pharma : Q1 2020 results
May 11, 2020: Amryt Pharma : FY 2019 results
Mar 23, 2020: AMRYT PHARMA: Strong cash balances coupled with revenue progression
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Amryt Pharma Plc, Key Facts
Amryt Pharma Plc, Key Employees
Amryt Pharma Plc, Key Employee Biographies
Amryt Pharma Plc, Major Products and Services
Amryt Pharma Plc, History
Amryt Pharma Plc, Other Locations
Amryt Pharma Plc, Subsidiaries
Amryt Pharma Plc, Key Competitors
Amryt Pharma Plc, Ratios based on current share price
Amryt Pharma Plc, Annual Ratios
Amryt Pharma Plc, Annual Ratios (Cont...1)
Amryt Pharma Plc, Interim Ratios
Amryt Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amryt Pharma Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amryt Pharma Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Amryt Pharma Plc (AMYT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hindustan ZInc Ltd:企業の戦略・SWOT・財務情報
    Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Karyopharm Therapeutics Inc (KPTI):企業の財務・戦略的SWOT分析
    Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Hogg Robinson Group Limited:企業の戦略・SWOT・財務分析
    Hogg Robinson Group Limited - Strategy, SWOT and Corporate Finance Report Summary Hogg Robinson Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Eguana Technologies Inc (EGT):企業の財務・戦略的SWOT分析
    Eguana Technologies Inc (EGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • BioVentrix Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioVentrix Inc (BioVentrix) is a medical device company that develops congestive heart failure treatment solutions. The company offers revivent myocardial anchoring systems, a device that restores the size, volume and resulting function of the left ventricle for improving cardiac function in …
  • Bacardi Limited:企業の戦略・SWOT・財務情報
    Bacardi Limited - Strategy, SWOT and Corporate Finance Report Summary Bacardi Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Orcas Power & Light Cooperative:企業の戦略的SWOT分析
    Orcas Power & Light Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Gilead Sciences, Inc.:企業のM&A・事業提携・投資動向
    Gilead Sciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gilead Sciences, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Breas Medical AB-医療機器分野:企業M&A・提携分析
    Summary Breas Medical AB (Breas), a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co Ltd, is a medical device company that manufactures and markets medical devices for anesthesia and respiratory markets. The company offers isleep and vivo products. It offers products such as isleep, vivo 30, v …
  • Driver and Vehicle Standards Agency:企業の戦略的SWOT分析
    Driver and Vehicle Standards Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Genting Plantations Berhad (GENP):企業の財務・戦略的SWOT分析
    Genting Plantations Berhad (GENP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • ConocoPhillips (COP)-エネルギー分野:企業M&A・提携分析
    Summary ConocoPhillips is an independent upstream oil and gas company. The company explore for, produce, transport and market crude oil, bitumen, natural gas, liquefied natural gas (LNG) and natural gas liquids across the world. It has assets across North America, Europe, Asia and Australia. Its ass …
  • Western Areas Limited:企業の戦略・SWOT・財務情報
    Western Areas Limited - Strategy, SWOT and Corporate Finance Report Summary Western Areas Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Universities Superannuation Scheme Ltd:企業の戦略的SWOT分析
    Universities Superannuation Scheme Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Trina Solar Co Ltd (688599):企業の財務・戦略的SWOT分析
    Trina Solar Co Ltd (688599) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Konica Minolta, Inc.:企業の戦略・SWOT・財務分析
    Konica Minolta, Inc. - Strategy, SWOT and Corporate Finance Report Summary Konica Minolta, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Kura Oncology Inc (KURA):企業の財務・戦略的SWOT分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate Tipifarnib, an inhibitor of farnesyl transferase, an oral investigational drug candi …
  • Andhra Pradesh Power Generation Corporation Ltd:電力:M&Aディール及び事業提携情報
    Summary Andhra Pradesh Power Generation Corporation Limited (APGENCO) is a state-owned electricity utility that that conducts the generation, operation, maintenance and execution of energy projects. The company owns, operates, and maintains thermal, hydel and wind power plants. APGENCO also undertak …
  • Fresenius SE & Co KGaA (FRE)-製薬・医療分野:企業M&A・提携分析
    Summary Fresenius SE & Co KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It provides various dialysis services through its own clinics and sells its products to other dialysis service providers. Its major products and services includes mach …
  • Dynasty Fine Wine Group Limited:企業の戦略・SWOT・財務分析
    Dynasty Fine Wine Group Limited - Strategy, SWOT and Corporate Finance Report Summary Dynasty Fine Wine Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆